Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02166229Phase 1/2Withdrawn
Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
SclerodermaSystemic Sclerosis
Principalinvestigator
NCT02812342Phase 2Completed
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Alopecia AreataAlopecia TotalisAlopecia Universalis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02166229Phase 1/2PrincipalInvestigator

Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma

SclerodermaSystemic Sclerosis
Withdrawn
NCT02812342Phase 2PrincipalInvestigator

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Alopecia AreataAlopecia TotalisAlopecia Universalis
Completed

All 2 trials loaded